Back to search

Aristotle University Of Thessaloniki (AUTH)

Η συμβολή των ανοσοϊστοχημικών ευρημάτων σε συνδυασμό με τα κλινικά και ιστολογικά ευρήματα στην πρόγνωση του καρκίνου του μαστού

Abstract

dc:description

Breast cancer is the first reason of death among the women and also is the most frequent cancer of the women. The detection of the disease has become very interesting the last years. There is no, as yet, a single tumor index sufficiently specific to predict with accuracy the outcome for each breast cancer patient. In recent years, progress in biochemistry and molecular biology had allowed the determination of various proteins who were studied for the prognostic significance in breast cancer patients. The most studies are about the biology of the disease. The detection of tumor markers in an effort to find earlier the recurrence of the disease is very interesting. From the systemic review of the literature the most studies measures these markers with immunohistochemical methods. From these studies appears that these markers can be used after further studies for the follow-up of the patients.In our study 100 patients with breast cancer are enrolled. We measured HER2, p53m, at tumor tissue ( method of measurement:anisoistochemical). The purpose of our study was to examine if these markers can detect the recurrence of the disease and if they have correlations with the classic prognostic tumor markers. The results have been analyzed with statistical methods ( Pearson, 2-tailed sig.).From the statistical analysis we found that:1.Age has significant correlation with tumor size, node status, ER and PR receptors and with values of HER2, p53.2.Node status has not significant correlation with expression of HER2 and p53.3.ER has not significant correlation with PR.4.There is no correlation between HER2 and p53 in tumor tissue.5.In spite the worse prognostic role of the oncoprotein HER2, the presence of estrogen and progesterone receptors at the same time have been associated with decreased metastatic potential.6.The (ER+PR+) tumors had a tendency to have not lymph node metastasis.7. The (ER+PR+) tumors had a tendency to have HER2- over expression.8.The patients with PR+ tumors had a tendency to have higher overall 5-years survival.9.Young women with stage T1tumors had more lymph node involvement.10. The tumor size was significantly different between the young and the older patients with less T4 tumors in the very young group and prevalence of the T1 tumors. This trend of young patients to have smaller size tumors at diagnosis, is controversial with the trend that young patients have larger tumor size at diagnosis.11. The triple-negative phenotype was presented by 3% and was significantly associated with older age,more advanced stage at diagnosis, poorly differentiated histology, lower SES and shortened survival. Our results showed very low proportion of triple-negative breast cancers.12. Young women with breast cancer seems to have a lower overall survival than the older one.Τhe goal of identifying potential prognostic and predictive biomarkers in breast cancer patients, is the application and incorporation of these markers in the clinical practice by offering the opportunity to individualize cancer treatment. In base the latest data on cancer treatment and the introduction of the term “target treatment” in the clinical practice, the knowledge of the biological ways of cancer extension will identify subgroups of patients with need of different confront.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papaefthymiou, Lamprini
  • Παπαευθυμίου, Λαμπρινή

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36957

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papaefthymiou, Lamprini; Παπαευθυμίου, Λαμπρινή. Η συμβολή των ανοσοϊστοχημικών ευρημάτων σε συνδυασμό με τα κλινικά και ιστολογικά ευρήματα στην πρόγνωση του καρκίνου του μαστού. Aristotle University Of Thessaloniki (AUTH), 2013. http://hdl.handle.net/10442/hedi/36957